GH Research PLC - Ordinary Shares (GHRS)

Gh Research Plc is a biotechnology company focused on developing innovative therapies for neurological disorders, particularly those related to psychedelics

The company is dedicated to harnessing the therapeutic potential of 5-MeO-DMT, a naturally occurring psychoactive compound, to create treatments aimed at addressing conditions such as depression and anxiety. By conducting rigorous research and clinical trials, Gh Research aims to advance the understanding and efficacy of psychedelic-assisted therapy, ultimately enhancing the quality of life for patients suffering from these challenging mental health issues. The company's mission emphasizes a commitment to scientific excellence and the responsible development of its products in the medical field.